Literature DB >> 11834118

Electromyographic comparison of standard and modified closed-chain isometric knee extension exercises.

Timothy J Brindle1, John Nyland, Kevin Ford, Alfonse Coppola, Robert Shapiro.   

Abstract

The purpose of this study was to compare electromyographic (EMG) activity during open kinetic chain (OKC) and a modified closed kinetic chain (MCKC) knee extension exercises. Both OKC and closed kinetic chain (CKC) exercises provide benefits when devising conditioning programs; however, there are no exercises that combine the benefits of both exercises. Subjects performed maximum isometric knee extensions for both traditional OKC and MCKC knee extension exercises. Surface electrodes were placed on 8 lower-extremity muscles. One second of integrated EMG activity followed 95% maximal knee extension force. The following muscles demonstrated greater EMG activity during the MCKC vs. the OKC knee extension exercises: vastus medialis, medial hamstring, lateral hamstrings, and gluteus maximus. There was no difference between force output between the 2 conditions. This study demonstrates that modifications to traditional OKC exercises demonstrate some characteristics of CKC exercises, and therefore provide another avenue of rehabilitation or strengthening.

Entities:  

Mesh:

Year:  2002        PMID: 11834118

Source DB:  PubMed          Journal:  J Strength Cond Res        ISSN: 1064-8011            Impact factor:   3.775


  2 in total

1.  EMG-Informed Musculoskeletal Modeling to Estimate Realistic Knee Anterior Shear Force During Drop Vertical Jump in Female Athletes.

Authors:  Alessandro Navacchia; Ryo Ueno; Kevin R Ford; Christopher A DiCesare; Gregory D Myer; Timothy E Hewett
Journal:  Ann Biomed Eng       Date:  2019-07-09       Impact factor: 3.934

2.  Preferential quadriceps activation in female athletes with incremental increases in landing intensity.

Authors:  Kevin R Ford; Gregory D Myer; Laura C Schmitt; Timothy L Uhl; Timothy E Hewett
Journal:  J Appl Biomech       Date:  2011-08       Impact factor: 1.833

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.